Morgan Stanley Portfolio holdings
Morgan Stanley, founded in 1935 by Henry Sturgis Morgan and Harold Stanley as a spin-off from J.P. Morgan & Co., is a leading global financial services firm headquartered in New York City. Initially focused on investment banking, it has evolved into a diversified powerhouse offering wealth management, institutional securities, and asset management services, catering to corporations, governments, institutions, and high-net-worth individuals. With a strong presence in mergers and acquisitions, underwriting, and trading, Morgan Stanley manages billions in assets and is known for its sophisticated financial advisory services. The firm has adapted to modern markets by expanding its digital offerings and wealth management division, notably through its 2020 acquisition of E*TRADE, solidifying its position as a Wall Street titan.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard FTSE Developed Markets ETF
VEA
|
+$1.69B |
| 2 |
State Street SPDR Portfolio S&P 500 ETF
SPYM
|
+$1.32B |
| 3 |
Vanguard Total Bond Market
BND
|
+$1.21B |
| 4 |
SPDR Gold Trust
GLD
|
+$970M |
| 5 |
State Street SPDR Portfolio S&P 500 Growth ETF
SPYG
|
+$842M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$7.66B |
| 2 |
Invesco QQQ Trust
QQQ
|
+$5.23B |
| 3 |
Accenture
ACN
|
+$1.14B |
| 4 |
Advanced Micro Devices
AMD
|
+$1.13B |
| 5 |
Vanguard Short-Term Bond ETF
BSV
|
+$635M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 25.17% |
| 2 | Technology | 22.44% |
| 3 | Financials | 11.14% |
| 4 | Consumer Discretionary | 8.06% |
| 5 | Healthcare | 8.02% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
126
Pfizer
PFE
$168B
| $2.22B | 0.13% |
89,113,604
+14,342,946
| +19% | +$362M |
2013 Q2
50 quarters
|
|
127
iShares 1-3 Year Treasury Bond ETF
SHY
$26.8B
| $2.21B | 0.13% |
26,646,281
-7,023,607
| -21% | -$582M |
2013 Q2
50 quarters
|
|
128
Invesco MSCI USA ETF
PBUS
$10.7B
| $2.2B | 0.13% |
32,156,914
+5,280,388
| +20% | +$359M |
2020 Q2
22 quarters
|
|
129
Stryker
SYK
$112B
| $2.2B | 0.13% |
6,249,585
-206,998
| -3% | -$75.4M |
2013 Q2
50 quarters
|
|
130
Boston Scientific
BSX
$64B
| $2.19B | 0.13% |
22,960,556
+2,246,308
| +11% | +$220M |
2013 Q2
50 quarters
|
|
131
State Street SPDR Bloomberg 1-3 Month T-Bill ETF
BIL
$50.8B
| $2.18B | 0.13% |
23,815,971
-990,206
| -4% | -$90.7M |
2013 Q2
50 quarters
|
|
132
iShares Core S&P Small-Cap ETF
IJR
$103B
| $2.17B | 0.13% |
18,064,089
+86,538
| +0.5% | +$10.3M |
2013 Q2
50 quarters
|
|
133
Adobe
ADBE
$97.9B
| $2.17B | 0.13% |
6,195,038
-717,953
| -10% | -$244M |
2013 Q2
50 quarters
|
|
134
Progressive
PGR
$124B
| $2.16B | 0.13% |
9,488,160
-845,167
| -8% | -$191M |
2013 Q2
50 quarters
|
|
135
Synopsys
SNPS
$89.7B
| $2.15B | 0.13% |
4,573,980
+109,917
| +2% | +$48.8M |
2013 Q2
50 quarters
|
|
136
Royalty Pharma
RPRX
$26.5B
| $2.14B | 0.13% |
55,274,069
+11,110,115
| +25% | +$424M |
2020 Q2
22 quarters
|
|
137
Texas Instruments
TXN
$255B
| $2.13B | 0.13% |
12,294,129
+69,176
| +0.6% | +$11.8M |
2013 Q2
50 quarters
|
|
138
KLA
KLAC
$228B
| $2.11B | 0.13% |
17,338,660
+137,320
| +0.8% | +$16.1M |
2013 Q2
50 quarters
|
|
139
Capital One
COF
$122B
| $2.1B | 0.13% |
8,677,981
+323,350
| +4% | +$72M |
2013 Q2
50 quarters
|
|
140
Northrop Grumman
NOC
$71B
| $2.09B | 0.12% |
3,667,833
+3,082
| +0.1% | +$1.79M |
2013 Q2
50 quarters
|
|
141
Ecolab
ECL
$81.5B
| $2.07B | 0.12% |
7,883,084
+441,747
| +6% | +$118M |
2013 Q2
50 quarters
|
|
142
Sherwin-Williams
SHW
$81.8B
| $2.05B | 0.12% |
6,313,220
-1,001,282
| -14% | -$335M |
2013 Q2
50 quarters
|
|
143
Nu Holdings
NU
$71.2B
| $2.03B | 0.12% |
121,350,701
+3,419,077
| +3% | +$54.9M |
2021 Q4
16 quarters
|
|
144
Vanguard Morningstar Small-Cap ETF
VB
$77.9B
| $2.03B | 0.12% |
7,864,543
+84,999
| +1% | +$21.8M |
2013 Q2
50 quarters
|
|
|
145
Accenture
ACN
$138B
| $2.02B | 0.12% |
7,536,001
-4,496,538
| -37% | -$1.14B |
2013 Q2
50 quarters
|
|
146
iShares Gold Trust
IAU
$61.9B
| $2.02B | 0.12% |
24,895,743
+59,272
| +0.2% | +$4.64M |
2013 Q2
50 quarters
|
|
147
Williams Companies
WMB
$84.7B
| $2.02B | 0.12% |
33,572,067
+3,314,851
| +11% | +$200M |
2013 Q2
50 quarters
|
|
148
Vanguard Intermediate-Term Corporate Bond ETF
VCIT
$67.2B
| $2.01B | 0.12% |
24,048,406
+4,399,400
| +22% | +$370M |
2013 Q2
50 quarters
|
|
149
Arthur J. Gallagher & Co
AJG
$64.1B
| $2.01B | 0.12% |
7,773,808
-811,982
| -9% | -$215M |
2013 Q2
50 quarters
|
|
150
Deere & Co
DE
$175B
| $1.98B | 0.12% |
4,251,054
-8,648
| -0.2% | -$4.06M |
2013 Q2
50 quarters
|
|
Similar funds
Morgan Stanley's Q4 2025 Portfolio in Review
As of Q4 2025, Morgan Stanley held 8,587 positions worth $1.67T, up 1.4% from $1.65T the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Morgan Stanley's Q4 2025 filing shows 428 new, 3,944 increased, 2,959 reduced and 385 closed positions. Its largest new stake was Medline Inc: 15,162,060 shares worth $637M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $7.66B.
By sector, the portfolio is most concentrated in Miscellaneous at 25% of assets, up from 25% a quarter earlier, followed by Technology and Financials.
- Morgan Stanley's largest Q4 2025 buy was Medline Inc: 15,162,060 shares worth $637M.
- Morgan Stanley added most to Vanguard FTSE Developed Markets ETF in Q4 2025, an estimated $1.69B increase.
- Morgan Stanley's biggest Q4 2025 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $7.66B.
- Morgan Stanley fully exited Mr. Cooper in Q4 2025, selling an estimated $312M.
- Morgan Stanley's ten largest holdings make up 22% of its $1.67T portfolio in Q4 2025.
- Morgan Stanley opened 428 new positions and closed 385 in Q4 2025.
- Morgan Stanley's portfolio value rose 1.4% quarter-over-quarter to $1.67T.
Based on Morgan Stanley's 13F filing for Q4 2025, filed 13 Feb 2026.